Skip to main content
Figure 4 | BMC Genomics

Figure 4

From: Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines

Figure 4

Functional characterization of candidate genes. Knockdown of individual genes in cancer cell lines followed by MTS assays to determine the effect of the candidate gene on AraC. Data are shown for 11 validated out of the 26 candidate genes tested in SU86, MDA-MB-231, BDCM, and THP-1 cancer cell lines by MTS assay after siRNA knockdown performed with a pool of 4 specific siRNAs. The drug dose response curves were obtained with the MTS assays. Red lines indicate the negative control siRNA pool, while blue lines indicate data obtained with specific siRNA pool. The x-axis indicates the log10 AraC concentration and the y-axis indicates the proportion of cells surviving after drug exposure. The bar graphs at the bottom show knockdown efficiency tested by QRT-PCR assay using the same transfected cells as those used to perform the MTS assays. The y-axis indicates relative gene expression after siRNA knockdown when compared with negative control siRNA. The experiments were repeated 3 times and the error bar represents SEM. Each of the genes was significantly knocked down when compared to the negsiRNA control, P<0.05.

Back to article page